Correlation of Fluorodeoxyglucose (FDG) PET Biomarkers (SUVmax, SUVpeak, TLG, and MTV) With Histopathological and Biochemical Parameters in FDG-Avid Lung Carcinoma. [PDF]
D A, S P, Panda DK, Kumar S.
europepmc +1 more source
Metabolic and morphological assessment of carbon ion radiotherapy response in sacral chordoma. [PDF]
Gantumur B +8 more
europepmc +1 more source
Programmable Pore Environments in Multivariate ZIF Membranes for Ultra-Selective Helium Recovery from Natural Gas. [PDF]
Liu Y +8 more
europepmc +1 more source
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patients. [PDF]
Arafa AT +18 more
europepmc +1 more source
Prognostic value as metabolic tumor activity on <sup>18</sup>F-FDG uptake in thymic epithelial tumors. [PDF]
Hashimoto K +11 more
europepmc +1 more source
[<sup>67</sup>Ga]Ga-citrate SPECT/CT and [<sup>18</sup>F]FDG-PET/CT for evaluating therapeutic response in necrotizing otitis externa. [PDF]
Vosbeek EGM +5 more
europepmc +1 more source
High TLG measured by PET/CT is associated with worse PFS in patients with advanced HR+ breast cancer treated by abemaciclib combined with endocrine therapy. [PDF]
Yang X +14 more
europepmc +1 more source
Bioengineering developmentally inspired matrix vesicles as designer nanotherapeutics for bone regeneration. [PDF]
Staubli F +6 more
europepmc +1 more source
Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative review. [PDF]
Walter KA +10 more
europepmc +1 more source
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy. [PDF]
Suh M +14 more
europepmc +1 more source

